Who is sponsoring NCT05472675?

NCT05472675 is sponsored by Pamukkale University.

What drugs are being tested in NCT05472675?

Interventions in NCT05472675: Botulinum toxin and bupivacain.

What condition does NCT05472675 study?

NCT05472675 studies Vestibular Migraine.

Is NCT05472675 still recruiting?

NCT05472675 is currently completed. Last updated 4 June 2025.

Last reviewed 2025-06-04 · How we verify

NCT05472675

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Local Sensory Nerve Block in the Treatment of Vestibular Migraine

Completed NA Last updated 4 June 2025

What this trial tests

NA trial testing Botulinum toxin and bupivacain in Vestibular Migraine in 29 participants. Completed in 1 June 2024.

Timeline

14 July 2022

Primary endpoint
1 June 2024

1 June 2024

Quick facts

Lead sponsor	Pamukkale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	29
Start date	14 July 2022
Primary completion	1 June 2024
Estimated completion	1 June 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Botulinum toxin and bupivacain

Conditions studied

Vestibular Migraine — all drugs for Vestibular Migraine →

Sponsor

Pamukkale University

Who can join

Adults 18 to 75, any sex, with Vestibular Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no standard approach to the treatment of vestibular migraine. Agents used in the treatment of migraine are frequently used. In treating migraine, local anesthetic agents, nerve-blocking methods, and botulinum toxin local injection is commonly applied, and successful results are obtained. Adapting the nerve-blocking method used in the treatment of migraine to the treatment of vestibular migraine is the purpose of the study.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Pharmacological interventions for prophylaxis of vestibular migraine.
Webster K, Dor A, Galbraith K, Kassem LH, et al · · 2023 · cited 19× · PMID 37073858 · DOI 10.1002/14651858.cd015187.pub2
Efficacy of Low-Dose BoNT-A Acupoint Injections in Managing Headache, Vertigo, and Allodynia in Vestibular Migraine.
Aydemir G, Aydemir G, Ardıç FN, Kara CO, et al · · 2025 · PMID 40693647 · DOI 10.5152/iao.2025.251876

Verify or expand the search:

Other recruiting trials for Vestibular Migraine

Currently open trials in the same condition.

NCT06992674 — The R-E-V-I-V-A-L Study · Phase 2 · active not recruiting
NCT07518069 — Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes · recruiting
NCT06540235 — The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines · NA · active not recruiting
NCT05418218 — International Headache Registry Study · recruiting
NCT04939922 — China Headache and Vertigo Registry Study · recruiting

Other Pamukkale University trials

Trials by the same sponsor.

NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05472675 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
Last refreshed: 4 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05472675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing